Overview of the safety of felodipine based on clinical trials in patients with hypertension.
作者信息
Welin L, Elvelin L, Niklasson A, Olsson G, Elmfeldt D
机构信息
Clinical R&D, Astra Hassle AB, Molndal, Sweden.
出版信息
Am J Cardiol. 1997 Apr 1;79(7):996-9. doi: 10.1016/s0002-9149(97)00034-9.
PMID:9104926
Abstract
All clinical studies of at least 1 week's duration with felodipine in patients with hypertension were included in a safety analysis. The major finding was that felodipine does not increase mortality or the incidence of major cardiovascular events and that the data indicate a favorable effect.
摘要
Zotero 插件